688139 海尔生物
已收盘 03-27 15:00:00
资讯
新帖
简况
海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%
证券之星 · 03-28 17:04
海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%
3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股
证券之星 · 03-23
3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股
每周股票复盘:海尔生物(688139)海外收入占比达36%
证券之星 · 03-22
每周股票复盘:海尔生物(688139)海外收入占比达36%
海尔生物(688139)披露2025年年度业绩说明会安排,3月19日股价下跌1.76%
证券之星 · 03-19
海尔生物(688139)披露2025年年度业绩说明会安排,3月19日股价下跌1.76%
【机构调研记录】宏利基金调研海尔生物、统联精密
证券之星 · 03-18
【机构调研记录】宏利基金调研海尔生物、统联精密
股市必读:海尔生物(688139)3月17日披露最新机构调研信息
证券之星 · 03-18
股市必读:海尔生物(688139)3月17日披露最新机构调研信息
海尔生物:公司所处行业具有“大市场、小细分、多产品、多应用”的特点
证券日报 · 03-03
海尔生物:公司所处行业具有“大市场、小细分、多产品、多应用”的特点
每周股票复盘:海尔生物(688139)2025年营收增2.0%至23.3亿
证券之星 · 03-01
每周股票复盘:海尔生物(688139)2025年营收增2.0%至23.3亿
海尔生物(688139.SH)2025年度归母净利润2.5亿元,下滑31.6%
智通财经 · 02-27
海尔生物(688139.SH)2025年度归母净利润2.5亿元,下滑31.6%
新产业、新市场与新技术动能澎湃,海尔生物2025年营收超23亿元
证券之星 · 02-27
新产业、新市场与新技术动能澎湃,海尔生物2025年营收超23亿元
每周股票复盘:海尔生物(688139)股东户数增至1.42万户
证券之星 · 02-08
每周股票复盘:海尔生物(688139)股东户数增至1.42万户
海尔生物(688139)1月31日股东户数1.42万户,较上期增加1.33%
证券之星 · 02-03
海尔生物(688139)1月31日股东户数1.42万户,较上期增加1.33%
每周股票复盘:海尔生物(688139)股东拟减持不超0.85%股份
证券之星 · 02-01
每周股票复盘:海尔生物(688139)股东拟减持不超0.85%股份
每周股票复盘:海尔生物(688139)股东户数增5.33%,达1.4万户
证券之星 · 01-25
每周股票复盘:海尔生物(688139)股东户数增5.33%,达1.4万户
海尔生物(688139)1月20日股东户数1.4万户,较上期增加5.33%
证券之星 · 01-22
海尔生物(688139)1月20日股东户数1.4万户,较上期增加5.33%
每周股票复盘:海尔生物(688139)回购股份308.79万股
证券之星 · 01-18
每周股票复盘:海尔生物(688139)回购股份308.79万股
海尔生物(688139)1月10日股东户数1.33万户,较上期增加1.59%
证券之星 · 01-13
海尔生物(688139)1月10日股东户数1.33万户,较上期增加1.59%
海尔生物(688139)披露完成工商变更登记并换发营业执照,1月9日股价上涨1.42%
证券之星 · 01-09
海尔生物(688139)披露完成工商变更登记并换发营业执照,1月9日股价上涨1.42%
股市必读:海尔生物(688139)股东户数1.31万户,较上期减少1.91%
证券之星 · 2025-12-31
股市必读:海尔生物(688139)股东户数1.31万户,较上期减少1.91%
海尔生物(688139)11月30日股东户数1.34万户,较上期减少0.98%
证券之星 · 2025-12-19
海尔生物(688139)11月30日股东户数1.34万户,较上期减少0.98%
暂无数据
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":30.65,"timestamp":1774594800000,"preClose":30.23,"halted":0,"volume":2148248,"delay":0,"changeRate":0.0139,"floatShares":316000000,"shares":316000000,"eps":0.8085,"marketStatus":"已收盘","change":0.42,"latestTime":"03-27 15:00:00","open":29.92,"high":30.72,"low":29.9,"amount":65319900,"amplitude":0.0271,"askPrice":30.67,"askSize":18,"bidPrice":30.65,"bidSize":29,"shortable":0,"etf":0,"ttmEps":0.8085,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.23,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":33.25,"lowLimit":27.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.24,"roa":"--","peRate":37.909709,"roe":"4.56%","epsLYR":1.16,"committee":-0.27027,"marketValue":9701000000,"turnoverRate":0.0068,"status":0,"afterMarket":{"amount":0,"volume":0,"close":30.65,"buyVolume":0,"sellVolume":0,"time":1774596837558,"indexStatus":"已收盘 03-27 15:30:00","preClose":30.23},"floatMarketCap":9701000000},"requestUrl":"/m/hq/s/688139/tweets","defaultTab":"tweets","newsList":[{"id":"2622385270","title":"海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385270","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622385270?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:04","pubTimestamp":1774688674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年2月28日公司股东户数为1.39万户,较1月31日减少309.0户,减幅为2.17%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至2月28日,医疗器械行业平均股东户数为2.16万户。从股价来看,2026年1月31日至2026年2月28日,海尔生物区间跌幅为1.47%,在此期间股东户数减少309.0户,减幅为2.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"gpt_icon":0},{"id":"2621477682","title":"3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621477682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621477682?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:35","pubTimestamp":1774254922,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日海尔生物跌5.52%创60日新低,收盘报30.1元,换手率1.53%,成交量4.84万手,成交额1.48亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为汇添富基金的汇添富中证互联网医疗指数A。汇添富中证互联网医疗指数A目前规模为0.63亿元,最新净值0.928,较上一交易日下跌2.35%,近一年下跌6.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"gpt_icon":0},{"id":"2621796781","title":"每周股票复盘:海尔生物(688139)海外收入占比达36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796781","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796781?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:20","pubTimestamp":1774117223,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,海尔生物报收于31.86元,较上周的32.0元下跌0.44%。本周,海尔生物3月18日盘中最高价报33.89元。本周关注点来自机构调研要点:2025年海尔生物AI相关收入占比为15%。2025年海尔生物海外业务收入8.4亿元,同比增长17.9%,占公司主营收入比重达36%,较2024年提升5个百分点。公司公告汇总海尔生物将于2026年3月30日15:00-16:00通过上证路演中心召开2025年年度业绩说明会,介绍年度经营成果与财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"gpt_icon":0},{"id":"2620243972","title":"海尔生物(688139)披露2025年年度业绩说明会安排,3月19日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620243972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620243972?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:04","pubTimestamp":1773911094,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘,海尔生物报收于32.85元,较前一交易日下跌1.76%,最新总市值为103.97亿元。该股当日开盘33.28元,最高33.5元,最低32.55元,成交额达1.11亿元,换手率为1.07%。公告显示,公司将于2026年3月30日15:00-16:00通过上证路演中心网络互动方式召开2025年年度业绩说明会,介绍公司年度经营成果及财务状况。投资者可于2026年3月23日至27日16:00前通过上证路演中心网站或公司邮箱提交问题。公司将在说明会上对普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900027269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2620340494","title":"【机构调研记录】宏利基金调研海尔生物、统联精密","url":"https://stock-news.laohu8.com/highlight/detail?id=2620340494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620340494?lang=zh_cn&edition=full","pubTime":"2026-03-18 08:04","pubTimestamp":1773792241,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及3月17日披露的机构调研信息,宏利基金近期对2家上市公司进行了调研,相关名单如下:1)海尔生物 调研纪要:海尔生物在AI领域推进“I+自动化”融合,推出IncGPT-BiolifeSci大模型及17个智能体,2025年AI相关收入占比达15%。2)统联精密 调研纪要:2025年公司实现营业收入85,682.18万元,同比增长5.25%,但净利润亏损464.99万元,主要因新产品与新业务投入加大,产能前置致成本难以摊薄。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800006990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","BK0251","LU2488822045.USD","688139","688210"],"gpt_icon":0},{"id":"2620472594","title":"股市必读:海尔生物(688139)3月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620472594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620472594?lang=zh_cn&edition=full","pubTime":"2026-03-18 01:57","pubTimestamp":1773770231,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘,海尔生物报收于32.89元,下跌0.18%,换手率1.22%,成交量3.86万手,成交额1.28亿元。来自机构调研要点:2025年海尔生物海外业务收入达8.4亿元,同比增长17.9%,占主营收入比重提升至36%。来自机构调研要点:海尔生物提出未来三年实现“双50”战略目标,即海外收入占比和新产业收入占比均提升至50%。机构调研要点公司2025年AI相关收入占比为15%,主要来源于智慧用药、AI自动化样本库、细胞自动化工作站等产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800001180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2616132869","title":"海尔生物:公司所处行业具有“大市场、小细分、多产品、多应用”的特点","url":"https://stock-news.laohu8.com/highlight/detail?id=2616132869","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616132869?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:39","pubTimestamp":1772541540,"startTime":"0","endTime":"0","summary":"证券日报网3月3日讯 ,海尔生物在接受调研者提问时表示,公司所处行业具有“大市场、小细分、多产品、多应用”的特点,从底层技术角度来看各细分赛道差异明显,因此以外延并购快速切入新赛道、以投后整合逐步提升整体竞争力、最终打造覆盖多场景的平台型企业,是公司中长期持续发展的关键所在。上市以来,公司已完成6起并购,并购方向是为公司现有用户提供同一场景下更多的产品和持续的服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhptkrh7466561.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhptkrh7466561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2616457438","title":"每周股票复盘:海尔生物(688139)2025年营收增2.0%至23.3亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2616457438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616457438?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:10","pubTimestamp":1772305821,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,海尔生物报收于32.85元,较上周的32.63元上涨0.67%。本周,海尔生物2月25日盘中最高价报33.29元。海尔生物当前最新总市值103.97亿元,在医疗器械板块市值排名38/129,在两市A股市值排名2031/5189。公司公告汇总海尔生物2025年度业绩快报显示,公司实现营业总收入23.3亿元,同比增长2.0%;归母净利润2.5亿元,同比下降31.61%。海外收入达8.4亿元,同比增长17.9%,占主营业务收入比重为36%。新产业收入占比提升至48.5%,AI相关收入占比上升至15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139"],"gpt_icon":0},{"id":"2614573887","title":"海尔生物(688139.SH)2025年度归母净利润2.5亿元,下滑31.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614573887","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614573887?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:00","pubTimestamp":1772179231,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海尔生物 披露2025年度业绩快报,公司实现营业收入23.3亿元,同比增长2.0%;实现归母净利润2.5亿元,同比下滑31.6%。2025年公司实现国内收入14.7亿元,同比下滑5.5%。2025年公司新产业收入占比48.5%,同比增速8.8%。低温存储产业收入占比51.5%,同比下滑3.9%,继第三季度增长转正后,第四季度增长提速,渐进走出底部。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688139"],"gpt_icon":0},{"id":"2614887963","title":"新产业、新市场与新技术动能澎湃,海尔生物2025年营收超23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614887963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614887963?lang=zh_cn&edition=full","pubTime":"2026-02-27 15:59","pubTimestamp":1772179178,"startTime":"0","endTime":"0","summary":"2月27日晚间,海尔生物发布了2025年业绩快报,公司去年实现营业收入23.3亿元,同比增长2.0%,第四季度收入同比增速13.1%,环比持续改善。新产业、新市场和AI引擎动能澎湃,海尔生物展现出强大发展韧性。从财报信息来看,AI技术应用已给公司业绩带来直接驱动力,2025年公司AI相关收入占整体收入比重达15%,较2024年提升2.5个百分点。新产业、新市场、新技术三重驱动力综合作用下,海尔生物已在2025年成功重塑增长曲线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026022700023802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300832","688139"],"gpt_icon":0},{"id":"2609526239","title":"每周股票复盘:海尔生物(688139)股东户数增至1.42万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526239","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526239?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:18","pubTimestamp":1770491893,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,海尔生物报收于32.41元,较上周的33.34元下跌2.79%。本周,海尔生物2月2日盘中最高价报33.35元。2月3日盘中最低价报32.13元。海尔生物当前最新总市值102.58亿元,在医疗器械板块市值排名38/129,在两市A股市值排名1978/5186。股本股东变化:户均持股数量由2.26万股下降至2.23万股。股本股东变化股东户数变动截至2026年1月31日,公司股东户数为1.42万户,较1月20日增加187.0户,增幅1.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2608821857","title":"海尔生物(688139)1月31日股东户数1.42万户,较上期增加1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608821857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608821857?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:36","pubTimestamp":1770111374,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年1月31日公司股东户数为1.42万户,较1月20日增加187.0户,增幅为1.33%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至1月31日,医疗器械行业平均股东户数为2.23万户。从股价来看,2026年1月20日至2026年1月31日,海尔生物区间跌幅为2.54%,在此期间股东户数增加187.0户,增幅为1.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300030047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2608070811","title":"每周股票复盘:海尔生物(688139)股东拟减持不超0.85%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608070811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608070811?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:44","pubTimestamp":1769888652,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海尔生物报收于33.34元,较上周的34.86元下跌4.36%。本周,海尔生物1月26日盘中最高价报35.24元。海尔生物当前最新总市值105.52亿元,在医疗器械板块市值排名36/127,在两市A股市值排名1946/5184。本周关注点公司公告汇总:青岛海创睿拟减持不超2,690,189股,占总股本不超过0.85%公司公告汇总青岛海创睿股权投资基金中心持有海尔生物32,103,659股,占总股本10.14%,因自身资金需求,拟通过集中竞价方式减持不超过2,690,189股,占公司总股本不超过0.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2606732232","title":"每周股票复盘:海尔生物(688139)股东户数增5.33%,达1.4万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2606732232","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606732232?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:11","pubTimestamp":1769281868,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,海尔生物报收于34.86元,较上周的34.81元上涨0.14%。本周,海尔生物1月23日盘中最高价报35.13元。1月22日盘中最低价报33.92元。海尔生物当前最新总市值110.33亿元,在医疗器械板块市值排名35/127,在两市A股市值排名1927/5182。户均持股数量由上期的2.38万股减少至2.26万股,户均持股市值为77.22万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0},{"id":"2605461282","title":"海尔生物(688139)1月20日股东户数1.4万户,较上期增加5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605461282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605461282?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:32","pubTimestamp":1769074368,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年1月20日公司股东户数为1.4万户,较1月10日增加709.0户,增幅为5.33%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至1月20日,医疗器械行业平均股东户数为2.19万户。从股价来看,2026年1月10日至2026年1月20日,海尔生物区间涨幅为4.11%,在此期间股东户数增加709.0户,增幅为5.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200028534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"gpt_icon":0},{"id":"2604235649","title":"每周股票复盘:海尔生物(688139)回购股份308.79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604235649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604235649?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:38","pubTimestamp":1768675090,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,海尔生物报收于34.81元,较上周的32.86元上涨5.93%。本周,海尔生物1月14日盘中最高价报38.8元,股价触及近一年最高点。公司公告汇总:海尔生物完成股份回购,实际回购3,087,899股,占总股本0.9757%。股本股东变化股东户数变动截至2026年1月10日,海尔生物股东户数为1.33万户,较2025年12月31日增加208.0户,增幅1.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"gpt_icon":0},{"id":"2603025805","title":"海尔生物(688139)1月10日股东户数1.33万户,较上期增加1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603025805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603025805?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:34","pubTimestamp":1768296881,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年1月10日公司股东户数为1.33万户,较12月31日增加208.0户,增幅为1.59%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至1月10日,医疗器械行业平均股东户数为2.19万户。从股价来看,2025年12月31日至2026年1月10日,海尔生物区间涨幅为3.4%,在此期间股东户数增加208.0户,增幅为1.59%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"gpt_icon":0},{"id":"2602837493","title":"海尔生物(688139)披露完成工商变更登记并换发营业执照,1月9日股价上涨1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602837493","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602837493?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:28","pubTimestamp":1767968892,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,海尔生物报收于32.86元,较前一交易日上涨1.42%,最新总市值为104亿元。近日,海尔生物发布公告称,公司已于近期完成工商变更登记并取得新换发的营业执照。公司已将回购专用账户中的1,459,586股股份用途由“用于员工持股计划或股权激励”调整为“用于注销并相应减少注册资本”,并已完成相关工商变更登记手续,注册资本变更为316,492,922元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"gpt_icon":0},{"id":"2595712396","title":"股市必读:海尔生物(688139)股东户数1.31万户,较上期减少1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595712396","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595712396?lang=zh_cn&edition=full","pubTime":"2025-12-31 03:53","pubTimestamp":1767124388,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,海尔生物报收于31.89元,上涨0.76%,换手率0.52%,成交量1.66万手,成交额5292.86万元。当日关注点来自交易信息汇总:12月30日主力资金净流入441.07万元,占总成交额8.33%。股本股东变化股东户数变动截至2025年12月19日,公司股东户数为1.31万户,较11月30日减少255.0户,减幅为1.91%。户均持股数量由上期的2.38万股增加至2.42万股,户均持股市值为76.42万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100004137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"gpt_icon":0},{"id":"2592915048","title":"海尔生物(688139)11月30日股东户数1.34万户,较上期减少0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915048","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592915048?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:43","pubTimestamp":1766137388,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2025年11月30日公司股东户数为1.34万户,较11月20日减少133.0户,减幅为0.98%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至11月30日,医疗器械行业平均股东户数为2.19万户。从股价来看,2025年11月20日至2025年11月30日,海尔生物区间跌幅为2.64%,在此期间股东户数减少133.0户,减幅为0.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900027030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774810235108,"stockEarnings":[{"period":"1week","weight":-0.038},{"period":"1month","weight":-0.0681},{"period":"3month","weight":-0.0319},{"period":"6month","weight":-0.049},{"period":"1year","weight":-0.1331},{"period":"ytd","weight":-0.0356}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"13900人(较上一季度减少2.17%)","perCapita":"22769股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}